GL1X · GenesisL1 explorer

MolNFT v1 · #7853 · protein

Engineering inhibitors highly selective for the S1 sites of SER190 trypsin-like serine protease drug targets

1GJ8 · Urokinase-type plasminogen activator: “Engineering inhibitors highly selective for the S1 sites of SER190 trypsin-like serine protease drug targets”. X-ray diffraction, 1 ligand (133), 1 pocket (best druggability 0.41). MolNFT v1…

PDB
1GJ8
Type
protein
Length
258 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Urokinase-type plasminogen activator
EC
3.4.21.73
UniProt
P00749
Ligands
133
Pockets
1 · best druggability 0.41

Structure

x-ray diffraction · 2 distinct chains · 12% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUrokinase-type plasminogen activatorprotein1331% helix, 0% strandP00749
BUrokinase-type plasminogen activator (EC 3.4.21.73)protein24511% helix, 40% strandP00749

Ligands and binding sites

  • 133 · 6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine · ligand · chains B
  • CIT · Citric acid · additive · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1950.410.7825133

Interfaces

1 interface between chains.

  • A–B · 547 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 1GJ8 · Engineering inhibitors highly selective for the S1 sites of SER190 trypsin-like serine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.